Surveillance for Adverse Events Following Pandemic H1N1 Immunization

CompletedOBSERVATIONAL
Enrollment

6,525

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Novel Influenza A/H1N1
Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Institut National en Santé Publique du Québec

OTHER

collaborator

Laval University

OTHER

collaborator

CHU de Quebec-Universite Laval

OTHER

collaborator

Queen Elizabeth II Health Sciences Centre

OTHER

collaborator

Mount Sinai Hospital, New York

OTHER

collaborator

The Ottawa Hospital

OTHER

collaborator

Hamilton Health Sciences Corporation

OTHER

collaborator

Alberta Children's Hospital

OTHER

collaborator

Vancouver General Hospital

OTHER

lead

PHAC/CIHR Influenza Research Network

OTHER_GOV

NCT01289418 - Surveillance for Adverse Events Following Pandemic H1N1 Immunization | Biotech Hunter | Biotech Hunter